March 2026 in “Folia Histochemica et Cytobiologica” LTBP1 is a key regulator in diseases and a potential target for new treatments.
March 2026 in “Journal of Clinical Oncology” Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.
February 2026 in “JAAD International” December 2025 in “Journal of Dermatological Treatment” GT20029 helps regrow hair in men with hair loss and is well-tolerated.
July 2025 in “Journal of Investigative Dermatology” Scarring alopecia involves increased immune cells and specific gene changes near damaged hair follicles.
July 2025 in “Plastic & Reconstructive Surgery” Managing expectations and using skilled techniques are key for patient satisfaction in hairline transplants.
July 2025 in “Annals of Medicine” Gestrinone pellets may help reduce pelvic pain in endometriosis safely.
A new sprayable hydrogel helps heal wounds faster and reduces inflammation.
June 2025 in “Bioactive Materials” April 2025 in “Asian Journal of Case Reports in Surgery” Trichilemmal carcinoma is a rare skin cancer that requires careful diagnosis and follow-up.
Topical GT20029 effectively promotes hair regrowth and is well-tolerated.
January 2025 in “Annals of Dermatology” Low-dose dutasteride effectively and safely promotes hair growth in men.
Topical GT20029 effectively promotes hair regrowth and is well-tolerated for treating androgenetic alopecia.
December 2024 in “Aesthetic Plastic Surgery” Combining PEMF with PBST is more effective for hair regrowth than PBST alone.
August 2024 in “Frontiers in Public Health” Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.
May 2024 in “Ultramicroscopy” Atomic Force Microscopy is a more accurate way to assess hair damage and the effect of cosmetic treatments.
February 2024 in “Al-Azhar International Medical Journal /Al-Azhar International Medical Journal” Betamethasone lotion works better for patchy hair loss.
September 2023 in “SKIN The Journal of Cutaneous Medicine” Talquetamab may cause hair loss and skin issues.
August 2023 in “Journal of The American Academy of Dermatology” Low-dose oral minoxidil is safe for treating hair loss, especially in women, with side effects stopping after use ends.
The human scalp has different types of pigment cells in hair follicles with varying abilities to produce pigment.
April 2023 in “Journal of Investigative Dermatology” Some patients who had a severe drug reaction developed long-term hair loss.
November 2022 in “Journal of Investigative Dermatology” KX-826 is safe and effectively increases hair count in men with hair loss.
November 2022 in “Journal of Investigative Dermatology” Aging in one type of stem cell can cause aging-like changes in various organs.
November 2022 in “Journal of the Endocrine Society” A woman's small ovarian tumor causing high androgen levels was missed by several scans but found during surgery.
May 2021 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature”
June 2019 in “Journal of Dermatological Treatment” BM-PHA is as effective and safe as Restylane Perlane for improving nasolabial folds with minor side effects.
January 2008 in “Zhonghua linchuang mianyi he biantai fanying zazhi” The treatment with Shunyou and prednisone is effective and safe for lupus nephritis.
July 2021 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature” May 2019 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature”
April 2012 in “The Journal of Urology” Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.